APA (7th ed.) Citation

Ata, B., & Humaidan, P. (2025). Response: As with all innovations, it may take a considerable time to change policies – the case of in-vitro maturation (IVM) Safety first, but not necessarily at the cost of effectiveness. Reproductive BioMedicine Online (Elsevier Science), 51(4), N.PAG. https://doi.org/10.1016/j.rbmo.2025.105156

Chicago Style (17th ed.) Citation

Ata, Baris, and Peter Humaidan. "Response: As with All Innovations, It May Take a Considerable Time to Change Policies – the Case of In-vitro Maturation (IVM) Safety First, but Not Necessarily at the Cost of Effectiveness." Reproductive BioMedicine Online (Elsevier Science) 51, no. 4 (2025): N.PAG. https://doi.org/10.1016/j.rbmo.2025.105156.

MLA (9th ed.) Citation

Ata, Baris, and Peter Humaidan. "Response: As with All Innovations, It May Take a Considerable Time to Change Policies – the Case of In-vitro Maturation (IVM) Safety First, but Not Necessarily at the Cost of Effectiveness." Reproductive BioMedicine Online (Elsevier Science), vol. 51, no. 4, 2025, p. N.PAG, https://doi.org/10.1016/j.rbmo.2025.105156.